Analogously, Taverna and colleagues showed that treatment of ECs with CML-derived small EVs led to an increase in IL-8 and VCAM1 levels, ultimately enhancing angiogenesis. This evidence concerns the gene VCAM1 and chronic myelogenous leukemia, BCR-ABL1 positive.